To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
August 1, 2005
The Damon Runyon Foundation has announced a new partnership with Berlex, Inc., a U.S. affiliate of Schering AG, Germany (NYSE:SHR). Berlex Oncology has committed $134,000 over three years to support Don X. Nguyen, PhD (Damon Runyon Fellow '05-'08). Dr. Nguyen's research focuses on breast cancer and understanding the genetic basis of its often-lethal spread (metastasis) to the lung.